Bevacizumab accelerates corneal wound healing by inhibiting TGF-β2 expression in alkali-burned mouse cornea = Bevacizumab accelerates corneal wound healing by inhibiting TGF-β2 expression in alkali-burned mouse cornea

참고문헌 (Reference)

1 Wilson, S. E, "The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, andinflammatory cells" 20 : 625-637, 2001

2 Dwivedi, D. J, "Targeted deletion of AP-2alpha leads to disruption in cornealepithelial cell integrity and defects in the cornealstroma" 46 : 3623-3630, 2005

3 Jester, J. V, "TGFbeta induced myofibroblast differentiationof rabbit keratocytes requires synergistic TGFbeta, PDGFand integrin signaling" 75 : 645-657, 2002

4 Evans, R. A, "TGF-beta1-mediated fibroblast-myofibroblast terminaldifferentiation-the role of Smad proteins" 282 : 90-100, 2003

5 Ormerod, L. D, "Standard models of corneal injury using alkali-immersedfilter discs" 30 : 2148-2153, 1989

6 Yoeruek, E, "Safety, penetration and efficacy of topically appliedbevacizumab: evaluation of eyedrops in corneal neovascularizationafter chemical burn" 86 : 322-328, 2008

7 Dawson, D. W, "Pigment epithelium-derived factor: a potent inhibitor of angiogenesis" 285 : 245-248, 1999

8 Rosenfeld, P. J, "Optical coherence tomography findings after an intravitrealinjection of bevacizumab (avastin) for macular edemafrom central retinal vein occlusion" 36 : 336-339, 2005

9 Desmouliere, A., "Normal and pathologic soft tissue remodeling: role of themyofibroblast, with special emphasis on liver and kidneyfibrosis" 83 : 1689-1707, 2003

10 Tomasek, J. J, "Myofibroblasts and mechano-regulationof connective tissue remodelling" 3 : 349-363, 2002

11 Stramer, B. M, "Molecular mechanisms controlling thefibrotic repair phenotype in cornea: implications for surgicaloutcomes" 44 : 4237-4246, 2003

12 Cursiefen, C, "Inhibition of hemangiogenesis andlymphangiogenesis after normal-risk corneal transplantationby neutralizing VEGF promotes graft survival" 45 : 2666-2673, 2004

13 Manzano, R. P, "Inhibition of experimental corneal neovascularisationby bevacizumab (Avastin)" 91 : 804-807, 2007

14 Burns, F. R, "Inhibition of alkali-induced corneal ulceration and perforationby a thiol peptide" 31 : 107-114, 1990

15 이지영, "Hitological Changes on the Wound Healing Process of Alkali Burned Mouse Cornea" 한국안광학회 13 (13): 161-169, 2008

16 Piek, E, "Functional characterizationof transforming growth factor beta signaling inSmad2- and Smad3-deficient fibroblasts" 276 : 19945-19953, 2001

17 Casey, R, "Factors controlling ocularangiogenesis" 124 : 521-529, 1997

18 Zhang, P, "Experimental inhibition of cornealneovascularization by endostatin gene transfection invivo" 116 : 1869-1874, 2003

19 Ormerod, L. D, "Dynamics of cornealepithelial healing after an alkali burn. A statisticalanalysis" 30 : 1784-1793, 1989

20 Stoltz, R. A, "Direct stimulationof limbal microvessel endothelial cell proliferationand capillary formation in vitro by a corneal-derivedeicosanoid" 148 : 129-139, 1996

21 Kao, W. W, "Development of monoclonal antibodiesrecognizing collagenase from rabbit PMN; thepresence of this enzyme in ulcerating corneas" 5 : 801-815, 1986

22 Chang, J. H, "Corneal neovascularization" 12 : 242-249, 2001

23 Chung, J. H, "Corneal alkaliwound healing in the monkey" 67 : 685-693, 1989

24 Bascom, C. C, "Complex regulation of transforming growth factorbeta 1, beta 2, and beta 3 mRNA expression in mousefibroblasts and keratinocytes by transforming growth factorsbeta 1 and beta 2" 9 : 5508-5515, 1989

25 Moromizato, Y, "CD18 and ICAM-1-dependent corneal neovascularizationand inflammation after limbal injury" 157 : 1277-1281, 2000

26 Ferrara, N, "Bevacizumab (Avastin), a humanized anti-VEGF monoclonalantibody for cancer therapy" 333 : 328-335, 2005

27 Hosseini, H, "A potential therapeuticstrategy for inhibition of corneal neovascularizationwith new anti-VEGF agents" 68 : 799-801, 2007